Tissue & cellHumansColorectal NeoplasmsSUMO-1 ProteinDrug ResistanceNeoplasm
SUMO1 promotes malignancy and chemoresistance in colorectal cancer: Clinical and functional evidence.
Anran Xu, Tianyuan Tan, Lin Yuan, Wei Yan, Yang Han, Su Lu
Published: 202610.1016/j.tice.2025.103191
Abstract
Colorectal cancer (CRC) patients often experience poor prognosis due to chemoresistance development, prompting investigation into the role of SUMO1 in CRC malignancy and treatment resistance. We initially analyzed tumor and adjacent normal tissues fr…
Preview only. Read the full abstract at the source